OncoResponse raises $40 million to kickstart immunotherapy drug development

OncoResponse’s discovery platform mines the immune systems of patients who have responded particularly well to cancer immunotherapies.

Read the original here:
OncoResponse raises $40 million to kickstart immunotherapy drug development